David Sudolsky is the President and Chief Executive Officer of Anellotech, which is developing the Bio-TCat™ process to produce cost-competitive renewable aromatic chemicals (benzene, toluene and xylenes, "BTX") from non-food biomass for use in making plastics such as polyester, nylon, polycarbonate, polystyrene, or for renewable transportation fuels.
Anellotech is currently evaluating loblolly pine and eventually other sustainable bio-feedstocks at its seven-story tall TCat-8® pilot plant. Anellotech complements its world-class R&D team with in-depth, long-term alliances with leaders to leverage decades of successful experience in developing and commercializing process technology. IFPEN is Anellotech's process development and scale-up partner, Johnson Matthey is the company's catalyst development partner, and Axens is Anellotech's partner for commercialization, global licensing and technical support. Industry-leading strategic partners in the BTX supply chain, including Suntory and Toyota Tsusho, as well as other confidential strategic investors, have provided funding to Anellotech.
Prior to founding Anellotech, Sudolsky was a business officer or CEO of five biotechnology, specialty pharmaceutical and bioprocessing start-ups, one of which (Dura Pharmaceuticals) was sold for $1.8 billion. Sudolsky has hands-on chemical engineering experience in process design and refinery plant startups with Union Carbide, and work at Booz, Allen & Hamilton. He is a firm believer in environmental education and co-led a successful five-year effort ending in 2011 to build a multi-faceted Eco Center on the roof of a public school in the middle of New York City. David attended Columbia University where he earned an MBA in Marketing and Finance from the University's Business School and a B.S. in Chemical Engineering.